Ladan Fazli

Also affiliated with Vancouver General Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling”.

IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling

Nature Communications(2019)10.1038/s41467-018-08152-3

N/A

0.817DataRank · unranked

231 citations

Hatice Zeynep Nenseth, Su Qu, Omer F. Kuzu, Turid Frahnow, Lukas M. Simon +12 more

Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis

Human Pathology(2022)10.1016/j.humpath.2022.01.009

N/A

0.489DataRank · unranked

25 citations

Yan Gao, Yi Ding, Ping Bu, Brian J. Miles, Angelo De Marzo +25 more

Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study

Modern Pathology(2023)10.1016/j.modpat.2023.100241

N/A

0.330DataRank · unranked

8 citations

Stephanie A. Harmon, Rachael Iseman, Olga Ludkowski, Heidi Auman, Sarah T. Hawley +28 more

Author Correction: IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling

Nature Communications(2024)10.1038/s41467-024-50645-x

N/A

0.104DataRank · unranked

1 citations

Hatice Zeynep Nenseth, Su Qu, Omer F. Kuzu, Turid Frahnow, Lukas M. Simon +12 more

Loss of feedback regulation between FAM3B and androgen receptor driving prostate cancer progression

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad215

N/A

0DataRank · unranked

16 citations

Lianjin Jin, Shanshan Bai, Zhan Liu, Shuo Wang, Beibei Shen +19 more

Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad184

N/A

0DataRank · unranked

9 citations

Xiaofei Wang, Evan W. Warner, Andrea Sboner, Matti Annala, Michael Sigouros +13 more

Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cells

Endocrine Related Cancer(2023)10.1530/erc-23-0010

N/A

0DataRank · unranked

3 citations

Satyam Bhasin, Liang Liu, Noushin Nabavi, Chi Wing Cheng, Kevin J. Tam +13 more

ABI1 regulates transcriptional activity of Androgen Receptor by novel DNA and AR binding mechanism

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.26.542350

N/A

0DataRank · unranked

4 citations

Xiang Li, Neeru Arya, Fan Zhang, Sonia H.Y. Kung, Ladan Fazli +18 more

A noncanonical AR addiction drives enzalutamide resistance in prostate cancer

Nature Communications(2021)10.1038/s41467-021-21860-7

N/A

0DataRank · unranked

90 citations

Ting Wei, Zhenqing Ye, Jacob J. Orme, Dong Lin, Haoyue Sheng +10 more

Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer

Nature Communications(2022)10.1038/s41467-022-32530-7

N/A

0DataRank · unranked

19 citations

Chris Kedong Wang, Htoo Zarni Oo, Irina Nelepcu, Nada Lallous, Charlotte B. Spliid +21 more

Correlation of ABI1 and PTEN expression during prostate tumor progression.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.172

N/A

0DataRank · unranked

0 citations

Anita Hryniewicz‐Jankowska, Xiang Li, Katarzyna Augoff, Csaba Papp, Disharee Das +11 more